60 Degrees Pharmaceuticals Income Statement (2022-2025) | SXTPW

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.05M0.17M-0.04M0.02M0.06M0.05M0.13M0.11M0.12M0.14M0.24M0.16M0.10M0.44M
Gross Profit -0.04M0.08M-0.20M-0.06M-0.12M-0.02M-0.02M0.04M0.04M0.02M0.12M0.09M0.05M-0.10M
Operating items
Research & Development 0.23M0.03M0.20M0.12M0.20M0.26M0.10M0.34M3.10M0.94M0.61M0.41M0.25M0.81M
Selling, General & Administrative 0.41M0.41M0.31M0.78M0.46M1.31M1.69M1.08M1.13M1.22M1.61M1.69M1.61M1.51M
Other Operating Expenses -0.05M730.00-0.07M0.02M0.02M
Operating Expenses 0.64M0.44M0.51M0.90M0.67M1.58M1.79M1.41M4.22M2.16M2.22M2.09M1.86M2.32M
Operating Income -0.69M-0.22M-0.68M-0.95M-0.79M-1.52M-1.89M-1.34M-4.19M-2.12M-2.07M-1.91M-1.60M-2.33M
EBIT -0.69M-0.22M-0.68M-0.95M-0.79M-1.52M-1.89M-1.34M-4.19M-2.12M-2.07M-1.91M-1.60M-2.33M
Non-operating items
Non Operating Investment Income -0.04M0.08M-0.12M-0.02M
Interest & Investment Income 5.70M-0.15M1.77M0.01M-0.04M0.02M0.03M-0.13M0.01M
Other Non Operating Income -0.02M0.15M-0.84M-1.06M6.11M0.03M0.02M0.02M0.03M0.03M0.01M0.03M
Non Operating Income 0.00M-0.01M-0.07M0.35M0.03M0.02M0.02M-0.41M0.03M0.01M0.03M
Net income details
EBT -2.15M-1.45M-1.67M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M
Tax Provisions 250.00250.00-250.0063.0063.0063.0061.0063.00438.00250.00-501.0063.000.00M250.00
Profit After Tax -2.15M-1.45M-1.67M-2.60M-3.34M4.18M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M
Income from Non-Controlling Interests -0.00M-0.00M0.01M0.00M-0.01M-0.01M-0.03M-0.00M-0.00M-713.00-0.00M-752.00-0.00M-712.00
Income from Continuing Operations -2.15M-1.45M-1.67M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M
Consolidated Net Income -2.15M-1.45M-1.67M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M
Income towards Parent Company -2.15M-1.45M-1.67M-2.60M-3.34M4.17M-2.05M0.43M-4.17M-2.16M-2.05M-1.88M-1.73M-2.32M
Preferred Dividend Payments 0.10M0.12M0.12M0.12M0.12M0.13M0.12M
Net Income towards Common Stockholders -2.15M-1.45M-1.66M-2.60M-3.34M4.09M-2.08M0.31M-4.29M-2.27M-2.18M-2.00M-1.73M-2.32M
Additional items
EPS (Basic) -0.96-0.61-0.70-1.13-16.849.13-31.321.83-21.12-4.65-4.80-1.56-1.18-0.66
EPS (Weighted Average and Diluted) -0.92-0.61-0.70-1.13-16.849.13-31.321.83-21.12-2.92-4.80-1.56-1.18-0.66
Shares Outstanding (Weighted Average) 2.35M2.39M2.37M2.30M0.20M0.45M0.07M0.17M0.20M0.49M0.45M1.28M1.47M3.68M
Shares Outstanding (Diluted Average) 2.35M2.39M2.37M2.30M0.20M0.45M0.07M0.17M0.20M2.15M0.45M1.28M1.47M3.68M
EBITDA -2.26M-1.46M-1.65M-2.60M-3.34M4.19M-1.99M0.43M-4.17M-2.16M-2.05M-1.89M-1.60M-2.33M
Interest Expenses 0.91M1.22M1.11M1.14M1.10M0.04M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Shares Outstanding 2.39M2.39M0.04M0.20M0.20M0.48M0.10M0.20M0.20M0.37M0.57M1.47M1.47M4.10M
Tax Rate -0.01-0.020.010.000.000.000.000.01-0.01-0.010.020.00-0.09-0.01